Fragile histidine triad protein: Structure, function, and its association with tumorogenesis

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 3, 2010, Pages 333-350

  Hassan, Md Imtaiyaz ^a   Naiyer, Abdullah ^a   Ahmad, Faizan ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Allele loss; Chromosome instability; Fragile histidine triad; Fragile site; Gene targeting; HIT gene family; Oncogene; Tumor suppressor gene

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; FRAGILE HISTIDINE TRIAD PROTEIN; HOMODIMER; HYDROLASE; MAGNESIUM ION; POLYPEPTIDE; RIBONUCLEOTIDE; TRANSFERASE; ACID ANHYDRIDE HYDROLASE; TUMOR PROTEIN;

ACUTE LEUKEMIA; AMINO ACID SEQUENCE; CARCINOGENESIS; CATALYSIS; CHILDHOOD LEUKEMIA; CHROMOSOME 3P; ESOPHAGUS CANCER; FHIT GENE; GENE DELETION; GENE EXPRESSION; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HYDROLYSIS; HYDROPHOBICITY; KIDNEY CARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; MOLECULAR GENETICS; NEOPLASM; PHYLOGENY; PHYSIOLOGY; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY;

ACID ANHYDRIDE HYDROLASES; AMINO ACID SEQUENCE; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; PHYLOGENY; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 77449141738     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0751-9     Document Type: Review

References (174)

1. M Ahmadian II Wistuba KM Fong, et al. 1997 Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands Cancer Res 57 3664 3668 1:CAS:528:DyaK2sXlvFentrw%3D 9288768
2. M Albitar T Manshouri C Gidel, et al. 2001 Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia Leuk Res 25 859 864 1:CAS:528:DC%2BD3MXmsFWrtr4%3D 11532518
3. MD Askari T Vo-Dinh 2004 Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy Biopolymers 73 510 523 1:CAS:528:DC%2BD2cXitV2lt7o%3D 14991669
4. R Baffa ML Veronese R Santoro, et al. 1998 Loss of FHIT expression in gastric carcinoma Cancer Res 58 4708 4714 1:CAS:528:DyaK1cXmslWrsbk%3D 9788626
5. R Baffa LG Gomella A Vecchione, et al. 2000 Loss of FHIT expression in transitional cell carcinoma of the urinary bladder Am J Pathol 156 419 424 1:CAS:528:DC%2BD3cXhtlGgur0%3D 10666370
6. LD Barnes PN Garrison Z Siprashvili, et al. 1996 Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′, 5′-P1,P3-triphosphate hydrolase Biochemistry 35 11529 11535 1:CAS:528:DyaK28XltVChtbY%3D 8794732
7. F Bianchi E Tagliabue S Menard, et al. 2007 Fhit expression protects against HER2-driven breast tumor development: unraveling the molecular interconnections Cell Cycle 6 643 646 1:CAS:528:DC%2BD2sXnvFCltL4%3D 17374991
8. C Brenner 2002 Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases Biochemistry 41 9003 9014 1:CAS:528: DC%2BD38Xkslehsb0%3D 12119013
9. C Brenner P Garrison J Gilmour, et al. 1997 Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins Nat Struct Biol 4 231 238 1:CAS:528:DyaK2sXhslenurk%3D 9164465
10. C Brenner HC Pace PN Garrison, et al. 1997 Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein Protein Eng 10 1461 1463 1:CAS:528:DyaK1cXitVWhs7Y%3D 9543008
11. C Brenner P Bieganowski HC Pace, et al. 1999 The histidine triad superfamily of nucleotide-binding proteins J Cell Physiol 181 179 187 1:CAS:528:DyaK1MXmsVChu7c%3D 10497298
12. P Bugert M Wilhelm G Kovacs 1997 FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas Genes Chromosomes Cancer 20 9 15 1:CAS:528:DyaK2sXmtFemsr4%3D 9290948
13. M Campiglio Y Pekarsky S Menard, et al. 1999 FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease Cancer Res 59 3866 3869 1:CAS:528:DyaK1MXlsVOltrw%3D 10463571
14. J Cao W Li J Xie, et al. 2006 Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication Surg Oncol 15 223 233 17382535
15. M Carapeti RC Aguiar H Sill, et al. 1998 Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells Br J Cancer 78 601 605 1:CAS:528:DyaK1cXlvVChu7c%3D 9744498
16. AR Chaudhuri IA Khan V Prasad, et al. 1999 The tumor suppressor protein Fhit. A novel interaction with tubulin J Biol Chem 274 24378 24382 1:CAS:528:DyaK1MXlsVOmsro%3D 10446217
17. DC Connolly DL Greenspan R Wu, et al. 2000 Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease Clin Cancer Res 6 3505 3510 1:CAS:528:DC%2BD3cXntFCis7s%3D 10999736
18. S Corbin ME Neilly R Espinosa 3rd, et al. 2002 Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors Cancer Res 62 3477 3484 1:CAS:528:DC%2BD38XkslWqtr4%3D 12067991
19. S De Flora F D'Agostini A Izzotti, et al. 2007 Molecular and cytogenetical alterations induced by environmental cigarette smoke in mice heterozygous for Fhit Cancer Res 67 1001 1006 17283132
20. J Deka J Kuhlmann O Muller 1998 A domain within the tumor suppressor protein APC shows very similar biochemical properties as the microtubule-associated protein tau Eur J Biochem 253 591 597 1:CAS:528:DyaK1cXkt1Sqt7s%3D 9654054
21. K Dreijerink E Braga I Kuzmin, et al. 2001 The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis Proc Natl Acad Sci USA 98 7504 7509 1:CAS:528:DC%2BD3MXkslWlsrc%3D 11390984
22. T Druck P Hadaczek TB Fu, et al. 1997 Structure and expression of the human FHIT gene in normal and tumor cells Cancer Res 57 504 512 1:CAS:528:DyaK2sXhtVKms7w%3D 9012482
23. ML Dustin GR Jacobson SW Peterson 1984 Effects of insulin receptor down-regulation on hexose transport in human erythrocytes J Biol Chem 259 13660 13663 1:CAS:528:DyaL2cXlvVCmtbw%3D 6389533
24. X Feng L Li Y Gao, et al. 2007 Fhit protein expression in lung cancer studied by high-throughput tissue microarray Bull Cancer 94 E8 11 17371765
25. B Ferens A Kawiak B Banecki, et al. 2009 Aberration of the enzymatic activity of Fhit tumor suppressor protein enhances cancer cell death upon photodynamic therapy similarly to that driven by wild-type Fhit Cancer Lett 280 101 109 1:CAS:528:DC%2BD1MXlvF2kt7Y%3D 19286306
26. LY Fong V Fidanza N Zanesi, et al. 2000 Muir-Torre-like syndrome in Fhit-deficient mice Proc Natl Acad Sci USA 97 4742 4747 1:CAS:528: DC%2BD3cXivFKjtb8%3D 10758156
27. RL Fouts GE Sandusky S Zhang, et al. 2003 Down-regulation of fragile histidine triad expression in prostate carcinoma Cancer 97 1447 1452 1:CAS:528:DC%2BD3sXisVKgsbs%3D 12627509
28. RB Gartenhaus 1997 Allelic loss determination in chronic lymphocytic leukemia by immunomagnetic bead sorting and microsatellite marker analysis Oncogene 14 375 378 1:CAS:528:DyaK2sXht1ajurg%3D 9018124
29. N Gayrard V Cacheux F Iborra, et al. 2008 Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation Arch Pathol Lab Med 132 965 973 18517280
30. SA Gayther P Barski SJ Batley, et al. 1997 Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours Oncogene 15 2119 2126 1:CAS:528:DyaK2sXnt1GhtbY%3D 9366528
31. A Gemma K Hagiwara Y Ke, et al. 1997 FHIT mutations in human primary gastric cancer Cancer Res 57 1435 1437 1:CAS:528:DyaK2sXis12lsrs%3D 9108441
32. TW Glover C Berger J Coyle, et al. 1984 DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes Hum Genet 67 136 142 1:CAS:528:DyaL2cXmtVGks7o%3D 6430783
33. TW Glover JF Coyle-Morris FP Li, et al. 1988 Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytes Cancer Genet Cytogenet 31 69 73 1:STN:280:DyaL1c7ltVOnug%3D%3D 3125959
34. JR Gnarra MI Lerman B Zbar, et al. 1995 Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis Semin Oncol 22 3 8 1:STN:280:DyaK2M7lvVyqtA%3D%3D 7855617
35. F Golebiowski A Szulc A Szutowicz, et al. 2004 Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit Arch Biochem Biophys 428 160 164 1:CAS:528:DC%2BD2cXls1WltLY%3D 15246872
36. VK Gopalakrishnan AG Banerjee JK Vishwanatha 2003 Effect of FHIT gene replacement on growth, cell cycle and apoptosis in pancreatic cancer cells Pancreatology 3 293 302 1:CAS:528:DC%2BD3sXlvV2js7s%3D 12890991
37. DL Greenspan DC Connolly R Wu, et al. 1997 Loss of FHIT expression in cervical carcinoma cell lines and primary tumors Cancer Res 57 4692 4698 1:CAS:528:DyaK2sXnt12gtbg%3D 9354423
38. LA Guerin HT Hoffman MB Zimmerman, et al. 2006 Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma Arch Pathol Lab Med 130 158 164 1:CAS:528: DC%2BD28XitVCqurk%3D 16454554
39. E Guidi C Uboldi L Ferretti 2008 Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH) Cytogenet Genome Res 120 173 177 1:CAS:528:DC%2BD1cXlsFOmtLc%3D 18467844
40. G Guler K Huebner C Himmetoglu, et al. 2009 Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer Cancer 115 899 908 1:CAS:528:DC%2BD1MXjtF2qsLc%3D 19130459
41. XQ Guo SJ Wang LW Zhang, et al. 2007 DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area J Exp Clin Cancer Res 26 587 594 1:CAS:528:DC%2BD1cXitFSiu78%3D 18365557
42. P Hadaczek Z Siprashvili M Markiewski, et al. 1998 Absence or reduction of Fhit expression in most clear cell renal carcinomas Cancer Res 58 2946 2951 1:CAS:528:DyaK1cXkvVCntbw%3D 9679951
43. C Hallas M Albitar J Letofsky, et al. 1999 Loss of FHIT expression in acute lymphoblastic leukemia Clin Cancer Res 5 2409 2414 1:CAS:528: DyaK1MXmsFyjs7c%3D 10499611 (Pubitemid 29437320)
44. CJ Harrison 2001 Acute lymphoblastic leukaemia Best Pract Res Clin Haematol 14 593 607 1:CAS:528:DC%2BD38Xhs1OntA%3D%3D 11640871
45. S Hayashi K Tanimoto K Hajiro-Nakanishi, et al. 1997 Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases Cancer Res 57 1981 1985 1:CAS:528:DyaK2sXjtlGqtbg%3D 9157994
46. DT Hendricks R Taylor M Reed, et al. 1997 FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines Cancer Res 57 2112 2115 1:CAS:528:DyaK2sXjslGjur8%3D 9187105
47. A Hesketh K Ochi 1997 A novel method for improving Streptomyces coelicolor A3(2) for production of actinorhodin by introduction of rpsL (encoding ribosomal protein S12) mutations conferring resistance to streptomycin J Antibiot (Tokyo) 50 532 535 1:STN:280:DyaK2svhtF2jsg%3D%3D
48. H Hiraoka K Minami N Kaneko, et al. 2009 Molecular cloning of the canine fragile histidine triad (FHIT) gene and Fhit protein expression in canine peripheral blood mononuclear cells J Vet Med Sci 71 645 649 1:CAS:528: DC%2BD1MXnsF2isrw%3D 19498293
49. CH Holschneider RL Baldwin K Tumber, et al. 2005 The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer Clin Cancer Res 11 5756 5763 1:CAS:528:DC%2BD2MXos1Cjtr0%3D 16115913
50. HS Hsu TP Chen CH Hung, et al. 2007 Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma Cancer 110 2019 2026 1:CAS:528:DC%2BD2sXhtlertbrF 17876837
51. B Hu H Wang X Wang, et al. 2005 Fhit and CHK1 have opposing effects on homologous recombination repair Cancer Res 65 8613 8616 1:CAS:528: DC%2BD2MXhtVKiurfL 16204026
52. O Huber J Weiske 2008 Beta-catenin takes a HIT Cell Cycle 7 1326 1331 1:CAS:528:DC%2BD1cXptF2jtrw%3D 18596417
53. K Huebner CM Croce 2003 Cancer and the FRA3B/FHIT fragile locus: it's a HIT Br J Cancer 88 1501 1506 1:CAS:528:DC%2BD3sXktVent78%3D 12771912
54. K Huebner T Druck Z Siprashvili, et al. 1998 The role of deletions at the FRA3B/FHIT locus in carcinogenesis Recent Results Cancer Res 154 200 215 1:CAS:528:DyaK1cXmvFyrsL4%3D 10027001
55. K Huebner PN Garrison LD Barnes, et al. 1998 The role of the FHIT/FRA3B locus in cancer Annu Rev Genet 32 7 31 1:CAS:528:DyaK1MXjvFWmtg%3D%3D 9928473
56. D Iliopoulos G Guler SY Han, et al. 2005 Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer Oncogene 24 1625 1633 1:CAS:528:DC%2BD2MXhsFOqsbg%3D 15674328
57. T Iwai S Yokota M Nakao, et al. 1998 Frequent aberration of FHIT gene expression in acute leukemias Cancer Res 58 5182 5187 1:CAS:528: DyaK1cXnsFSmtLY%3D 9823330
58. LJ Jensen M Kuhn M Stark, et al. 2009 STRING 8-a global view on proteins and their functional interactions in 630 organisms Nucleic Acids Res 37 D412 D416 1:CAS:528:DC%2BD1cXhsFejt7jL 18940858
59. L Ji B Fang N Yen, et al. 1999 Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression Cancer Res 59 3333 3339 1:CAS:528: DyaK1MXks1Omsrk%3D 10416589
60. HM Kantarjian M Talpaz S O'Brien, et al. 1999 Significance of FHIT expression in chronic myelogenous leukemia Clin Cancer Res 5 4059 4064 1:CAS:528:DC%2BD3cXlsV2htw%3D%3D 10632340 (Pubitemid 30013785)
61. K Kastury R Baffa T Druck, et al. 1996 Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines Cancer Res 56 978 983 1:CAS:528:DyaK28XhtlKksLg%3D 8640789
62. KD Ki SK Lee SY Tong, et al. 2008 Role of 5′-CpG island hypermethylation of the FHIT gene in cervical carcinoma J Gynecol Oncol 19 117 122 1:CAS:528:DC%2BD1MXhslylu74%3D 19471558
63. I Kim GM Crippen GL Amidon 2004 Structure and specificity of a human valacyclovir activating enzyme: a homology model of BPHL Mol Pharm 1 434 446 1:CAS:528:DC%2BD2cXnslGqsbg%3D 16028355
64. LL Kisselev J Justesen AD Wolfson, et al. 1998 Diadenosine oligophosphates (Ap(n)A), a novel class of signalling molecules? FEBS Lett 427 157 163 1:CAS:528:DyaK1cXjtVKjt7o%3D 9607303
65. T Kitano W Tian K Umetsu, et al. 2006 Origin and evolution of gene for prolactin-induced protein Gene 383 64 70 1:CAS:528:DC%2BD28XhtFSgsr%2FF 16949771
66. AG Knudson 2000 Chasing the cancer demon Annu Rev Genet 34 1 19 1:CAS:528:DC%2BD3MXlvFKrtQ%3D%3D 11092820
67. T Kohno J Yokota 1999 How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis 20 1403 1410 1:CAS:528: DyaK1MXltlKgtbg%3D 10426784
68. K Kok SL Naylor CH Buys 1997 Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes Adv Cancer Res 71 27 92 1:CAS:528:DyaK2sXjvVOkur8%3D 9111863
69. A Koliopanos C Avgerinos C Paraskeva, et al. 2008 Molecular aspects of carcinogenesis in pancreatic cancer Hepatobiliary Pancreat Dis Int 7 345 356 1:CAS:528:DC%2BD1cXhtVKgtbfL 18693168
70. SM Kraggerud P Aman R Holm, et al. 2002 Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis Cancer Res 62 512 517 1:CAS:528:DC%2BD38XhtVyht7Y%3D 11809703
71. T Kuroki F Trapasso S Yendamuri, et al. 2003 Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma Cancer Res 63 3724 3728 1:CAS:528:DC%2BD3sXltVGqsr8%3D 12839965
72. AA Larson S Kern S Curtiss, et al. 1997 High resolution analysis of chromosome 3p alterations in cervical carcinoma Cancer Res 57 4082 4090 1:CAS:528:DyaK2sXmtFehsbY%3D 9307297
73. JS Lea R Ashfaq S Muneer, et al. 2004 Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development J Soc Gynecol Investig 11 329 337 1:CAS:528:DC%2BD2cXlt1Wmtr4%3D 15219888
74. SH Lee 2006 Differential gene expression in nickel(II)-treated normal rat kidney cells Res Commun Mol Pathol Pharmacol 119 77 87 1:CAS:528: DC%2BD2sXmt1OhsL8%3D 17974098
75. SH Lee CJ Kim HK Park, et al. 2001 Characterization of aberrant FHIT transcripts in gastric adenocarcinomas Exp Mol Med 33 124 130 1:CAS:528:DC%2BD3MXnvVGgsL8%3D 11642547
76. C Lengauer KW Kinzler B Vogelstein 1997 Genetic instability in colorectal cancers Nature 386 623 627 1:CAS:528:DyaK2sXisFCntrk%3D 9121588
77. CD Lima KL D'Amico I Naday, et al. 1997 MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family Structure 5 763 774 1:CAS:528:DyaK2sXks1ejsro%3D 9261067
78. PM Lin TC Liu JG Chang, et al. 1997 Aberrant FHIT transcripts in acute myeloid leukaemia Br J Haematol 99 612 617 1:CAS:528:DyaK2sXnvF2ls7Y%3D 9401074
79. DC Linehan PS Goedegebuure GE Peoples, et al. 1995 Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer J Immunol 155 4486 4491 1:CAS:528:DyaK2MXovFWlu7g%3D 7594611
80. LA Loeb 1991 Mutator phenotype may be required for multistage carcinogenesis Cancer Res 51 3075 3079 1:CAS:528:DyaK3MXksVKqsb8%3D 2039987
81. X Luan G Shi M Zohouri, et al. 1997 The FHIT gene is alternatively spliced in normal kidney and renal cell carcinoma Oncogene 15 79 86 1:CAS:528:DyaK2sXkslygsbY%3D 9233780
82. X Luan KH Ramesh LA Cannizzaro 1998 FHIT gene transcript alterations occur frequently in myeloproliferative and myelodysplastic diseases Cytogenet Cell Genet 81 183 188 1:CAS:528:DyaK1cXmtlOrtro%3D 9730598
83. R Lucito S Suresh K Walter, et al. 2007 Copy-number variants in patients with a strong family history of pancreatic cancer Cancer Biol Ther 6 1592 1599 1:CAS:528:DC%2BD1cXjslWlsL8%3D 17912030
84. L Mao 1998 Tumor suppressor genes: does FHIT fit? J Natl Cancer Inst 90 412 414 1:STN:280:DyaK1c7otVCmtg%3D%3D 9521159
85. A Matsuyama T Shiraishi F Trapasso, et al. 2003 Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic Proc Natl Acad Sci USA 100 14988 14993 1:CAS:528:DC%2BD3sXpvFaqtL8%3D 14630947
86. D Michael DG Beer CW Wilke, et al. 1997 Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas Oncogene 15 1653 1659 1:CAS:528:DyaK2sXmslClu74%3D 9349498
87. PS Moore S Beghelli G Zamboni, et al. 2003 Genetic abnormalities in pancreatic cancer Mol Cancer 2 7 12537585
88. M Mori K Mimori T Shiraishi, et al. 2000 Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus Cancer Res 60 1177 1182 1:CAS:528:DC%2BD3cXhvFWrsLY%3D 10728669
89. DJ Mulvihill YH Wang 2004 Two breakpoint clusters at fragile site FRA3B form phased nucleosomes Genome Res 14 1350 1357 1:CAS:528:DC%2BD2cXlvFWjtLw%3D 15231750
90. K Munger JA Pietenpol MR Pittelkow, et al. 1992 Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes Cell Growth Differ 3 291 298 1:CAS:528:DyaK3sXmtFyht74%3D 1633111
91. LC Murphy D Tsuyuki Y Myal, et al. 1987 Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D J Biol Chem 262 15236 15241 1:CAS:528:DyaL1cXhslSmsw%3D%3D 3667631
92. DM Muzny SE Scherer R Kaul, et al. 2006 The DNA sequence, annotation and analysis of human chromosome 3 Nature 440 1194 1198 1:CAS:528: DC%2BD28XjvVGltbg%3D 16641997
93. Y Myal DB Robinson B Iwasiow, et al. 1991 The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation Mol Cell Endocrinol 80 165 175 1:CAS:528:DyaK3MXmsV2gtrY%3D 1955075
94. M Negrini C Monaco I Vorechovsky, et al. 1996 The FHIT gene at 3p14.2 is abnormal in breast carcinomas Cancer Res 56 3173 3179 1:CAS:528: DyaK28XktlaqsL0%3D 8764101 (Pubitemid 26242956)
95. MK Neyaz RS Kumar S Hussain, et al. 2008 Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population Biomarkers 13 597 606 18608185
96. M Ohta N Hara 1986 Combined modality treatment of lung cancer: present and future Nihon Kyobu Shikkan Gakkai Zasshi 24 1186 1191 1:STN:280: DyaL2s7ntVCqtw%3D%3D 3031350
97. M Ohta T Kano Y Nishida, et al. 1986 Embryonal carcinoma (Higuchi, Kato) of the ovary, clinical analysis and recent improvement of treatment using alpha FP as a tumor marker Nippon Sanka Fujinka Gakkai Zasshi 38 887 895 1:STN:280:DyaL283nvF2jug%3D%3D 2426376
98. M Ohta H Inoue MG Cotticelli, et al. 1996 The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers Cell 84 587 597 1:CAS:528: DyaK28Xhtlemsrg%3D 8598045
99. H Okumura H Ishii F Pichiorri, et al. 2009 Fragile gene product, Fhit, in oxidative and replicative stress responses Cancer Sci 100 1145 1150 1:CAS:528:DC%2BD1MXosl2kt7Y%3D 19486340
100. M Osawa H Horiuchi W Tian, et al. 2004 Divergent evolution of the prolactin-inducible protein gene and related genes in the mouse genome Gene 325 179 186 1:CAS:528:DC%2BD3sXpvFCjsL8%3D 14697523
101. M Ottey SY Han T Druck, et al. 2004 Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant Br J Cancer 91 1669 1677 1:CAS:528:DC%2BD2cXptVOhur8%3D 15494723
102. RF Ozols 1994 Research directions in epithelial ovarian cancer Gynecol Oncol 55 S168 S173 1:STN:280:DyaK2M7jslCqtA%3D%3D 7835803
103. HC Pace PN Garrison AK Robinson, et al. 1998 Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit Proc Natl Acad Sci USA 95 5484 5489 1:CAS:528: DyaK1cXjtFWkt7o%3D 9576908
104. HC Pace SC Hodawadekar A Draganescu, et al. 2000 Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers Curr Biol 10 907 917 1:CAS:528:DC%2BD3cXlsFCmtLc%3D 10959838
105. I Panagopoulos N Pandis S Thelin, et al. 1996 The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14 Cancer Res 56 4871 4875 1:CAS:528:DyaK28XmsFygsbo%3D 8895736
106. N Pandis G Bardi F Mitelman, et al. 1997 Deletion of the short arm of chromosome 3 in breast tumors Genes Chromosomes Cancer 18 241 245 1:STN:280:DyaK2s3kt1Gltg%3D%3D 9087563 (Pubitemid 27161393)
107. AG Paulovich CD Armour LH Hartwell 1998 The Saccharomyces cerevisiae RAD9, RAD17, RAD24 and MEC3 genes are required for tolerating irreparable, ultraviolet-induced DNA damage Genetics 150 75 93 1:CAS:528:DyaK1cXmtFKhu7w%3D 9725831
108. R Pecherzewska B Nawrot 2009 FHIT-tumor suppressor protein involved in induction of apoptosis and cell cycle regulation Postepy Biochem 55 66 75 1:CAS:528:DC%2BD1MXhtl2qtr7F 19514467
109. Y Pekarsky M Campiglio Z Siprashvili, et al. 1998 Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans Proc Natl Acad Sci USA 95 8744 8749 1:CAS:528: DyaK1cXkvFalsLc%3D 9671749
110. Y Pekarsky T Druck MG Cotticelli, et al. 1998 The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells Cancer Res 58 3401 3408 1:CAS:528:DyaK1cXltFyisrc%3D 9699672
111. Y Pekarsky A Palamarchuk K Huebner, et al. 2002 FHIT as tumor suppressor: mechanisms and therapeutic opportunities Cancer Biol Ther 1 232 236 1:CAS:528:DC%2BD3sXlt1WisA%3D%3D 12432269
112. Y Pekarsky PN Garrison A Palamarchuk, et al. 2004 Fhit is a physiological target of the protein kinase Src Proc Natl Acad Sci USA 101 3775 3779 1:CAS:528:DC%2BD2cXis1Kgtbw%3D 15007172
113. UR Peters U Hasse E Oppliger, et al. 1999 Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia Oncogene 18 79 85 1:CAS:528:DyaK1MXhtVCmsro%3D 9926922
114. F Pichiorri F Trapasso T Palumbo, et al. 2006 Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35 Clin Cancer Res 12 3494 3501 1:CAS:528:DC%2BD28XltFyisLY%3D 16740775
115. F Pichiorri H Okumura T Nakamura, et al. 2009 Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions J Biol Chem 284 1040 1049 1:CAS:528: DC%2BD1MXhsVyqsQ%3D%3D 19004824
116. KS Poland M Azim M Folsom, et al. 2007 A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma Genes Chromosomes Cancer 46 805 812 1:CAS:528:DC%2BD2sXotlChtrY%3D 17539022
117. U Ramp E Caliskan T Ebert, et al. 2002 FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival J Pathol 196 430 436 1:CAS:528:DC%2BD38XjtVCgsLg%3D 11920739
118. FV Rassool MM Le Beau ML Shen, et al. 1996 Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2 Genomics 35 109 117 1:CAS:528:DyaK28Xkt12qsbw%3D 8661111
119. L Roz F Andriani CG Ferreira, et al. 2004 The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression Oncogene 23 9102 9110 1:CAS:528:DC%2BD2cXhtVehtb3L 15489891
120. M Rugge M Cassaro F Farinati, et al. 1996 Re: Helicobacter pylori and atrophic gastritis: importance of the cagA status J Natl Cancer Inst 88 762 763 1:STN:280:DyaK283hslKiuw%3D%3D 8637032
121. Y Sanchez A el-Naggar S Pathak, et al. 1994 A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo Proc Natl Acad Sci USA 91 3383 3387 1:CAS:528:DyaK2cXivFGntLw%3D 8159756
122. L Sard P Accornero S Tornielli, et al. 1999 The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control Proc Natl Acad Sci USA 96 8489 8492 1:CAS:528:DyaK1MXkslOksb0%3D 10411902
123. S Semba SY Han HR Qin, et al. 2006 Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor J Biol Chem 281 28244 28253 1:CAS:528: DC%2BD28XpsFOqsr8%3D 16864578
124. B Seraphin 1992 The HIT protein family: a new family of proteins present in prokaryotes, yeast and mammals DNA Seq 3 177 179 1:CAS:528: DyaK3sXnsFKgtg%3D%3D 1472710
125. Y Shi M Zou NR Farid, et al. 2000 Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9 Biochem J 352 Pt 2 443 448 1:CAS:528:DC%2BD3MXhtFahug%3D%3D 11085938
126. Y Shimada F Sato G Watanabe, et al. 2000 Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history Cancer 89 5 11 1:CAS:528:DC%2BD3cXltFKksbs%3D 10896994
127. T Shiraishi T Druck K Mimori, et al. 2001 Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit Proc Natl Acad Sci USA 98 5722 5727 1:CAS:528:DC%2BD3MXjs1Wnsb4%3D 11320209
128. R Shridhar V Shridhar X Wang, et al. 1996 Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors Cancer Res 56 4347 4350 1:CAS:528:DyaK28XmtVyltrg%3D 8813121
129. Z Siprashvili G Sozzi LD Barnes, et al. 1997 Replacement of Fhit in cancer cells suppresses tumorigenicity Proc Natl Acad Sci USA 94 13771 13776 1:CAS:528:DyaK2sXotValtbc%3D 9391102
130. KJ Smith DB Levy P Maupin, et al. 1994 Wild-type but not mutant APC associates with the microtubule cytoskeleton Cancer Res 54 3672 3675 1:CAS:528:DyaK2cXltVGmtr0%3D 8033082
131. DI Smith S McAvoy Y Zhu, et al. 2007 Large common fragile site genes and cancer Semin Cancer Biol 17 31 41 1:CAS:528:DC%2BD2sXltV2qsA%3D%3D 17140807
132. T Soma J Kaganoi A Kawabe, et al. 2006 Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells Int J Cancer 119 1023 1027 1:CAS:528:DC%2BD28Xns1Cms7o%3D 16570269
133. C Sorio A Baron S Orlandini, et al. 1999 The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers Cancer Res 59 1308 1314 1:CAS:528:DyaK1MXhvFehtbg%3D 10096564
134. G Sozzi ML Veronese M Negrini, et al. 1996 The FHIT gene 3p14.2 is abnormal in lung cancer Cell 85 17 26 1:CAS:528:DyaK28Xit1aksb4%3D 8620533 (Pubitemid 26116803)
135. G Sozzi S Tornielli E Tagliabue, et al. 1997 Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities Cancer Res 57 5207 5212 1:CAS:528:DyaK2sXnslGrtbc%3D 9393735
136. G Sozzi K Huebner CM Croce 1998 FHIT in human cancer Adv Cancer Res 74 141 166 1:CAS:528:DyaK1cXivVSls7o%3D 9561268
137. RW Stam ML den Boer MM Passier, et al. 2006 Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia Leukemia 20 264 271 1:CAS:528: DC%2BD28XmvVSisw%3D%3D 16357833
138. K Stec-Michalska S Antoszczyk G Klupinska, et al. 2005 Loss of FHIT expression in gastric mucosa of patients with family histories of gastric cancer and Helicobacter pylori infection World J Gastroenterol 11 17 21 1:CAS:528:DC%2BD2MXht1GmtLw%3D 15609389
139. T Su M Suzui L Wang, et al. 2003 Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis Proc Natl Acad Sci USA 100 7824 7829 1:CAS:528:DC%2BD3sXlt1Wqsb8%3D 12810953
140. K Sugimoto K Yamada K Miyagawa, et al. 1997 Decreased or altered expression of the FHIT gene in human leukemias Stem Cells 15 223 228 1:CAS:528:DyaK2sXjvF2nsLw%3D 9170214
141. J Sun H Okumura M Yearsley, et al. 2009 Nit1 and Fhit tumor suppressor activities are additive J Cell Biochem 107 1097 1106 1:CAS:528: DC%2BD1MXptlOntb4%3D 19479888
142. GR Sutherland 1991 Chromosomal fragile sites Genet Anal Tech Appl 8 161 166 1:CAS:528:DyaK38Xnslejsg%3D%3D 1721827
143. S Takada K Morita K Hayashi, et al. 2005 Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma Eur J Haematol 75 505 510 1:CAS:528:DC%2BD2MXhtlelsL%2FN 16313263
144. G Tamura K Sakata S Nishizuka, et al. 1997 Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines Genes Chromosomes Cancer 20 98 102 1:CAS:528:DyaK2sXmtFems70%3D 9290961
145. H Tanaka Y Shimada H Harada, et al. 1998 Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas Cancer Res 58 3429 3434 1:CAS:528:DyaK1cXltFyis7o%3D 9699676
146. S Thiagalingam C Lengauer FS Leach, et al. 1996 Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers Nat Genet 13 343 346 1:CAS:528:DyaK28XktVegt7s%3D 8673134
147. G Toledo JJ Sola MD Lozano, et al. 2004 Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer Mod Pathol 17 440 448 1:CAS:528:DC%2BD2cXmsVOitrc%3D 14976524
148. F Trapasso A Krakowiak R Cesari, et al. 2003 Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding Proc Natl Acad Sci USA 100 1592 1597 1:CAS:528:DC%2BD3sXhsFGkt7k%3D 12574506
149. F Trapasso F Pichiorri M Gaspari, et al. 2008 Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells J Biol Chem 283 13736 13744 1:CAS:528: DC%2BD1cXls12mu7Y%3D 18319262
150. T Tsujiuchi Y Sasaki T Kubozoe, et al. 2002 Alterations of the Fhit gene in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats Mol Carcinog 34 19 24 1:CAS:528:DC%2BD38Xjs1Wit74%3D 12112319
151. C Uboldi E Guidi S Roperto, et al. 2006 Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles BMC Genomics 7 123 16719907
152. A van den Berg CH Buys 1997 Involvement of multiple loci on chromosome 3 in renal cell cancer development Genes Chromosomes Cancer 19 59 76 9171996
153. A Vecchione H Ishii YH Shiao, et al. 2001 Fez1/lzts1 alterations in gastric carcinoma Clin Cancer Res 7 1546 1552 1:CAS:528:DC%2BD3MXltV2iu7Y%3D 11410489
154. L Virgilio M Shuster SM Gollin, et al. 1996 FHIT gene alterations in head and neck squamous cell carcinomas Proc Natl Acad Sci USA 93 9770 9775 1:CAS:528:DyaK28XlsFehsbk%3D 8790406
155. JM Walboomers MV Jacobs MM Manos, et al. 1999 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12 19 1:STN:280:DyaK1Mzot1CjsQ%3D%3D 10451482
156. J Weiske KF Albring O Huber 2007 The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity Proc Natl Acad Sci USA 104 20344 20349 1:CAS:528:DC%2BD1cXjt1agtw%3D%3D 18077326
157. T Wiech E Nikolopoulos R Weis, et al. 2009 Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays Lab Invest 89 385 397 1:CAS:528:DC%2BD1MXjs1Kht7k%3D 18663352
158. CM Wilke BK Hall A Hoge, et al. 1996 FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites Hum Mol Genet 5 187 195 1:CAS:528:DyaK28XptVCmsw%3D%3D 8824874
159. PA Wingo T Tong S Bolden 1995 Cancer statistics CA Cancer J Clin 45 8 30 1:STN:280:DyaK2M7gtlektA%3D%3D 7528632
160. II Wistuba AF Gazdar JD Minna 2001 Molecular genetics of small cell lung carcinoma Semin Oncol 28 3 13 1:CAS:528:DC%2BD3MXmsVyktbw%3D 11479891
161. M Woenckhaus J Merk R Stoehr, et al. 2008 Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer Hum Pathol 39 126 136 1:CAS:528:DC%2BD2sXhsVSls77I 17949785
162. Q Wu H Shi Z Suo, et al. 2003 5′-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas Ultrastruct Pathol 27 417 422 14660280
163. HW Yang HY Piao T Taki, et al. 1999 Pattern of FHIT gene expression in normal and leukaemic cells Int J Cancer 81 897 901 1:CAS:528:DyaK1MXktVantbk%3D 10362136
164. Q Yang G Yoshimura T Suzuma, et al. 2001 Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma Clin Cancer Res 7 3869 3873 1:CAS:528:DC%2BD38XltV2qsQ%3D%3D 11751477
165. Q Yang G Yoshimura T Sakurai, et al. 2002 The Fragile Histidine Triad gene and breast cancer Med Sci Monit 8 RA140 RA144 12118213
166. DT Yin XB Lu MM Dong, et al. 2004 Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma Ai Zheng 23 1338 1341 1:CAS:528:DC%2BD2MXotVCitQ%3D%3D 15522186
167. C Yin LJ Shen SM Xie, et al. 2005 Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions Di Yi Jun Yi Da Xue Xue Bao 25 812 814 1:CAS:528:DC%2BD2MXpsVWktLo%3D 16027075
168. K Yoshino T Enomoto T Nakamura, et al. 1998 Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix Int J Cancer 76 176 181 1:STN:280:DyaK1c7ps12htQ%3D%3D 9537577
169. J Zawacka-Pankau AJ Podhajska 2007 Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX Biotechnol Lett 29 877 883 1:CAS:528:DC%2BD2sXksVOnsLw%3D 17310323
170. P Zhao AK Lam YL Lu, et al. 2006 Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker Pathology 38 399 402 1:CAS:528:DC%2BD28XhtlCiurnK 17008276
171. P Zhao Y Lu M Zhong, et al. 2008 Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma Acta Oncol 47 1557 1563 1:CAS:528:DC%2BD1cXht1ymsrvF 18618300
172. S Zheng X Ma L Zhang, et al. 2004 Hypermethylation of the 5′ CpG island of the FHIT gene is associated with hyperdiploid and translocation- negative subtypes of pediatric leukemia Cancer Res 64 2000 2006 1:CAS:528:DC%2BD2cXitFCgtLY%3D 15026336
173. S Zochbauer-Muller KM Fong A Maitra, et al. 2001 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer Cancer Res 61 3581 3585 1:CAS:528:DC%2BD3MXjsFCgtLo%3D 11325823
174. S Zochbauer-Muller AF Gazdar JD Minna 2002 Molecular pathogenesis of lung cancer Annu Rev Physiol 64 681 708 1:CAS:528:DC%2BD38XisFGmsbc%3D 11826285